Ignite Creation Date:
2024-05-05 @ 11:44 PM
Last Modification Date:
2024-10-26 @ 10:38 AM
Study NCT ID:
NCT01402713
Status:
COMPLETED
Last Update Posted:
2015-01-26
First Post:
2011-07-25
Brief Title:
To Evaluate the EffectivenessImmunogenicity and Safety of GC1107 Administered Intramuscularly in Healthy Children
Sponsor:
Green Cross Corporation
Organization:
GC Biopharma Corp
Study Overview
Official Title:
Randomized Double Blind Multicenter Phase IIIII Study to Evaluate the EffectivenessImmunogenicity and Safety of GC1107 Administered Intramuscularly in Healthy Children
Status:
COMPLETED
Status Verified Date:
2015-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the effectivenessimmunogenicity and safety of GC1107 administered intramuscularly in healthy children
Detailed Description:
Randomized double blind multicenter phase ⅡⅢ study
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None